載入...
The natural history and treatment outcome of blast phase BCR-ABL(−) myeloproliferative neoplasms
We analyzed the outcomes of 74 patients diagnosed with BCR-ABL(−) myeloproliferative neoplasms in blast phase receiving induction chemotherapy (55%), low-intensity therapy (16%), stem cell transplantation (SCT; 3%), or supportive care (26%). Median survival from the date of blastic transformation wa...
Na minha lista:
| Main Authors: | , , , , , , , , , , , |
|---|---|
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
American Society of Hematology
2008
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2518875/ https://ncbi.nlm.nih.gov/pubmed/18566326 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2008-02-138230 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|